Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке:
https://open.uns.ac.rs/handle/123456789/32518
Назив: | β1-blockade increases maximal apnea duration in elite breath-hold divers | Аутори: | Ryan Hoiland Philip Ainslie Anthony Bain David MacLeod Mike Stembridge Ivan Drviš Dennis Madden Otto Barak Douglas MacLeod Željko Dujić |
Кључне речи: | Adrenergic beta-1 Receptor Antagonists;divers;apnea;Blood Pressure;Breath Holding;Oxygen Consumption;Oxyhemoglobins;Propanolamines;Stroke Volume | Датум издавања: | 2017 | Часопис: | Journal of Applied Physiology | Сажетак: | We hypothesized that the cardioselective β1-adrenoreceptor antagonist esmolol would improve maximal apnea duration in elite breath-hold divers. In elite national-level divers (n = 9), maximal apneas were performed in a randomized and counterbalanced order while receiving either iv esmolol (150 μg.kg-1.min-1) or volume-matched saline (placebo). During apnea, heart rate (ECG), beat-by-beat blood pressure, stroke volume (SV), cardiac output (CO), and total peripheral resistance (TPR) were measured (finger photoplethysmography). Myocardial oxygen consumption (MVO2) was estimated from rate pressure product. Cerebral blood flow through the internal carotid (ICA) and vertebral arteries (VA) was assessed using Duplex ultrasound. Apnea duration improved in the esmolol trial when compared with placebo (356 ± 57 vs. 323 ±61 s, P < 0.01) despite similar end-apnea peripheral oxyhemoglobin saturation (71.8 ± 10.3 vs. 74.9 ± 9.5%, P = 0.10). The HR response to apnea was reduced by esmolol at 10-30% of apnea duration, whereas MAP was unaffected. Esmolol reduced SV (main effect, P < 0.05) and CO (main effect; P < 0.05) and increased TPR (main effect, P < 0.05) throughout apnea. Esmolol also reduced MVO2 throughout apnea (main effect, P < 0.05). Cerebral blood flow through the ICA and VA was unchanged by esmolol at baseline and the last 30 s of apnea; however, global cerebral blood flow was reduced in the esmolol trial at end-apnea (P < 0.05). Our findings demonstrate that, in elite breath-hold divers, apnea breakpoint is improved by β1-blockade, likely owing to an improved total body oxygen sparring through increased centralization of blood volume (∵ TPR) and reduced MVO2. | URI: | https://open.uns.ac.rs/handle/123456789/32518 | ISSN: | 8750-7587 | DOI: | 10.1152/japplphysiol.00127.2016 |
Налази се у колекцијама: | MDF Publikacije/Publications |
Приказати целокупан запис ставки
Преглед/и станица
26
Протекла недеља
4
4
Протекли месец
4
4
проверено 15.03.2024.
Google ScholarTM
Проверите
Алт метрика
Ставке на DSpace-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.